Testing effectiveness (Phase 2)Ended earlyNCT02810951
What this trial is testing
FCX-007 for Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Who this might be right for
Epidermolysis Bullosa Dystrophica, Recessive
Castle Creek Biosciences, LLC. 6
Showing 20 of 150 results